NTQ Stock Overview
RiceBran Technologies, together with its subsidiaries, operates as a specialty ingredient company in the United States and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
RiceBran Technologies Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.29 |
| 52 Week High | US$1.20 |
| 52 Week Low | US$0.27 |
| Beta | 0.40 |
| 1 Month Change | 0% |
| 3 Month Change | 3.62% |
| 1 Year Change | -73.52% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -99.99% |
Recent News & Updates
Recent updates
Shareholder Returns
| NTQ | DE Food | DE Market | |
|---|---|---|---|
| 7D | 0% | 1.6% | 1.9% |
| 1Y | -73.5% | -20.7% | 4.6% |
Return vs Industry: NTQ underperformed the German Food industry which returned -14.3% over the past year.
Return vs Market: NTQ underperformed the German Market which returned -2.6% over the past year.
Price Volatility
| NTQ volatility | |
|---|---|
| NTQ Average Weekly Movement | n/a |
| Food Industry Average Movement | 4.1% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in DE Market | 10.4% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: NTQ has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine NTQ's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 94 | n/a | www.ricebrantech.com |
RiceBran Technologies, together with its subsidiaries, operates as a specialty ingredient company in the United States and internationally. It focuses on development, production, and marketing of products derived from rice and other small and ancient grains for the nutraceutical, healthy food, companion animal, and equine feed categories. The company converts raw rice bran into stabilized rice bran (SRB) and high value SRB derivative products, including RiBalance, a complete rice bran nutritional package derived from further processing of SRB; RiSolubles, a nutritious, carbohydrate, and lipid rich fraction of RiBalance; RiFiber, a protein and fiber rich insoluble derivative of RiBalance; and ProRyza products, which includes derivatives composed of protein and protein/fiber blends.
RiceBran Technologies Fundamentals Summary
| NTQ fundamental statistics | |
|---|---|
| Market cap | €1.15m |
| Earnings (TTM) | -€6.99m |
| Revenue (TTM) | €36.48m |
0.0x
P/S Ratio-0.2x
P/E RatioIs NTQ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NTQ income statement (TTM) | |
|---|---|
| Revenue | US$39.38m |
| Cost of Revenue | US$39.67m |
| Gross Profit | -US$290.00k |
| Other Expenses | US$7.26m |
| Earnings | -US$7.55m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.79 |
| Gross Margin | -0.74% |
| Net Profit Margin | -19.17% |
| Debt/Equity Ratio | -507.8% |
How did NTQ perform over the long term?
See historical performance and comparison